5141 related articles for article (PubMed ID: 2898751)
1. [Genetic polymorphism and susceptibility to cancer].
Larsen CJ
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
[TBL] [Abstract][Full Text] [Related]
2. [Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers].
Champème MH; Bièche I; Latil A; Hacène K; Lidereau R
Bull Cancer; 1992; 79(12):1149-57. PubMed ID: 1304834
[TBL] [Abstract][Full Text] [Related]
3. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
4. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
5. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
6. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
Ishikawa J; Maeda S; Kamidono S; Sugiyama T
Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphism and cancer susceptibility.
Larsen CJ
Pathol Biol (Paris); 1989 Nov; 37(9):955-6. PubMed ID: 2575241
[No Abstract] [Full Text] [Related]
8. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
9. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
Trench GC; Southall M; Smith P; Kidson C
Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
11. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
12. Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.
Ceccherini-Nelli L; De Re V; Viel A; Molaro G; Zilli L; Clemente C; Boiocchi M
Br J Cancer; 1987 Jul; 56(1):1-5. PubMed ID: 2887194
[TBL] [Abstract][Full Text] [Related]
13. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism of restriction fragments of the Ha-ras-1 protooncogene in patients with carcinoma and ulcers of the stomach].
Novikov LB; Fedorov SN; Iatsuk OS; Tlevlesov NIa; Levanova GI; Kalinovskiĭ VP; Seĭts IF
Eksp Onkol; 1989; 11(5):66-70. PubMed ID: 2571493
[TBL] [Abstract][Full Text] [Related]
15. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
[TBL] [Abstract][Full Text] [Related]
16. Ha-ras hypervariable alleles in myelodysplasia.
Thein SL; Oscier DG; Flint J; Wainscoat JS
Nature; 1986 May 1-7; 321(6065):84-5. PubMed ID: 3010134
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
Spinola M; Pedotti P; Dragani TA; Taioli E
Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
[TBL] [Abstract][Full Text] [Related]
18. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
19. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
[TBL] [Abstract][Full Text] [Related]
20. Human restriction fragment length polymorphisms and cancer risk assessment.
Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
